PPD

WILMINGTON, N.C., a leading global contract research organization, will host a conference call on Wednesday, April 28, 2021, at 8 a.m. (U.S. Eastern Time) to discuss its first quarter 2021 financial results. Investors and other interested parties may listen to a live webcast of the conference call by logging on to the investors section of PPD’s…

Read More
PPD

WILMINGTON, N.C. – PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, and Clinical Ink, a global clinical technology company, have jointly developed a systemic lupus erythematosus (SLE) assessment review process to simplify operationalizing clinical trials for this chronic autoimmune disease. The companies’ collaborative approach focuses on enhancing data quality and research site personnel experiences and efficiencies, in turn supporting…

Read More
PPD

Recognized for comprehensive strengths in the design, deployment of decentralized solutions WILMINGTON, N.C., PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, has been recognized for industry leadership in digital and decentralized clinical trial solutions by Information Services Group (ISG), a leading global technology research and advisory firm. ISG recognized PPD as an ISG Provider…

Read More
PPD

WILMINGTON, N.C. – PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, will present virtually at the Barclays Global Healthcare Conference. David Simmons, chairman and CEO, and Chris Scully, CFO, are scheduled to participate in a fireside chat on Tuesday, March 9, 2021, at 3:35 p.m. (U.S. Eastern Time). The presentation can be accessed live on…

Read More
PPD

WILMINGTON, N.C.  – PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, reported its financial results for the fourth quarter and full year ended December 31, 2020. Highlights Fourth quarter net authorizations of $1,297.6 million, representing 28.1% growth and resulting in a net book-to-bill ratio of 1.30x on a historical basis Full year net authorizations of $4,613.7 million, representing…

Read More
PPD

Adaptive platform clinical research trial design to expedite potential new treatments for veterans WILMINGTON, N.C., PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, has been awarded Defense Health Agency funds to support a five-year Research Project Award (RPA) to develop and execute an adaptive platform clinical research trial of drug interventions to treat post-traumatic…

Read More
PPD

Training magazine recognizes PPD for innovative training practices for 10th consecutive year WILMINGTON, N.C.  PPD, Inc. (Nasdaq: PPD) has been recognized for the 10th consecutive year as one of the leading U.S. businesses for employee learning and development. PPD was named to Training magazine’s Top 100 list, which honors companies that demonstrate measurable results from effective employee learning and development tied to strategic…

Read More
PPD

WILMINGTON, N.C.  – PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, will host a conference call on Wednesday, Feb. 24, 2021, at 9 a.m. (U.S. Eastern Time) to discuss its fourth quarter and full-year 2020 financial results. Investors and other interested parties may listen to a live webcast of the conference call by logging on…

Read More
PPD

WILMINGTON, N.C. — PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference. David Simmons, chairman and CEO, and Chris Scully, CFO, are scheduled to present on Monday, Jan. 11, 2021, at 2:50 p.m. (U.S. Eastern Time). A live and archived webcast of the presentation, along with…

Read More
PPD

WILMINGTON, N.C. – PPD, Inc. (Nasdaq:PPD) has been named one of the Best Workplaces in Greater China™ by Great Place to Work®, a global authority on high-trust, high-performance workplace cultures that provides executive advisory and culture consulting services to businesses, nonprofits and government agencies. The honor builds on the announcement by PPD to adopt a…

Read More